LORI RAMSEY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family JOPLIN, MO NPI 1013347400

General Payments — all program years on this page

$1,749.12

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 41
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $686.89 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $673.1318
Education $13.761

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $157.512
2022 $404.0811
2023 $500.649
2024 $686.8919

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1108058603 ABBVIE INC. $10.56 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108058605 ABBVIE INC. $88.23 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108058607 ABBVIE INC. $5.79 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108058609 ABBVIE INC. $122.70 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108058611 ABBVIE INC. $18.54 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135825386 Lilly USA, LLC $23.73 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137811896 Takeda Pharmaceuticals U.S.A., Inc. $13.76 04/01/2024 Education Undisputed 01/23/2026 View at CMS
1137811898 Takeda Pharmaceuticals U.S.A., Inc. $13.13 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146742614 Ardelyx, Inc. $125.14 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146742616 Ardelyx, Inc. $21.34 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146742618 Ardelyx, Inc. $30.37 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153420033 Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.60 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153439867 Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.39 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153557779 Salix Pharmaceuticals, a division of Bausch Health US, LLC $71.11 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153623929 Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.23 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153642605 Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.50 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153646154 Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.89 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153672237 Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.14 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153759798 IRONWOOD PHARMACEUTICALS, INC $15.74 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.